LONDON — The U.K.'s FTSE 100 closed higher by a whisker to keep its winning streak intact and be on par with its best run in 2017. Most other European markets closed for the May 1 holiday.

But the momentum for Novo Nordisk might be short-lived. Prescription data from health-analytics company Iqvia, tracked by Wall Street analysts, shows U.S. demand for Ozempic and Wegovy has been ...

Information About Us Contact us Feedback Terms Of Service Privacy Policy Subscriber Agreement JPost Jobs Cancel Subscription Sitemap Customer Service JP Store ...

Each telehealth company's price may be higher because they likely include additional services, a Novo Nordisk spokesperson told CNBC. Hims & Hers said it will begin offering all dose sizes of ...

SAN FRANCISCO - Novo Nordisk, a global healthcare company, and Hims & Hers Health, Inc. (NYSE: HIMS), a telehealth company, have announced a collaboration to enhance obesity care by making ...

SAN FRANCISCO - Novo Nordisk, a global healthcare company, and Hims & Hers Health, Inc. (NYSE: HIMS), a telehealth company, have announced a collaboration to enhance obesity care by making treatments ...

Shares in Hims & Hers Health, Inc. (NYSE: HIMS) are skyrocketing in early-morning trading today after the telehealth company announced a new partnership with the Danish pharmaceutical giant Novo ...

The lawsuit, filed late Thursday in the Superior Court of New Jersey, Middlesex County, accuses Novo Nordisk of negligence ... GLP-1 use and NAION. The company added that it takes reports ...

Novo Nordisk scored a huge legal victory that largely ... semaglutide' drugs are working," he said, referring to the company's more than 100 lawsuits against compounding pharmacies and other ...

the company said sales will grow only 16% to 24% this year, which is "a much slower pace than in the past few years." Digesting all this news, DBS Bank concludes Novo Nordisk's run is done and ...

"FDA's determination was based on a thorough review of Novo Nordisk's stable and growing supply of these important FDA-approved medicines. With the end of the shortage of Wegovy and Ozempic ...

Alphabet shares surged following the company’s first-quarter earnings report, which revealed strong double-digit growth in revenue and profit. The performance was propelled by continued strength in ...